Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
ZIVO Bioscience, Inc. (ZIVO) had Cost of Goods Sold of $0.02M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.03M |
|
$-7.78M |
|
|
Cost of Goods Sold |
$0.02M |
$0.01M |
|
$7.29M |
|
$-7.26M |
|
$-0.51M |
|
$-7.78M |
|
$-7.78M |
|
$-7.78M |
|
$-7.78M |
|
$-7.78M |
|
$-7.78M |
|
$-7.26M |
|
$-7.43M |
|
1.69M |
|
1.69M |
|
$-4.60 |
|
$-4.60 |
|
| Balance Sheet Financials | |
$0.43M |
|
-- |
|
$0.13M |
|
$0.56M |
|
$2.76M |
|
-- |
|
-- |
|
$2.76M |
|
$-2.21M |
|
$-2.21M |
|
$-2.21M |
|
2.38M |
|
| Cash Flow Statement Financials | |
$-5.80M |
|
-- |
|
$4.28M |
|
$1.80M |
|
$0.27M |
|
$-1.52M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.99% |
|
-26267.67% |
|
-26267.67% |
|
-26885.16% |
|
-28127.25% |
|
-28127.25% |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
7.40 |
|
49.30 |
|
352.57% |
|
352.57% |
|
-1399.49% |
|
352.57% |
|
$-0.93 |
|
$-3.43 |
|
$-3.43 |
|